Results 121 to 130 of about 49,526 (230)
In Vitro Activities of Voriconazole (UK-109,496) and Four Other Antifungal Agents against 394 Clinical Isolates of Candida spp [PDF]
Francesc Marco +3 more
openalex +1 more source
Hong Lu,* Yanmei Mao,* Ying Zeng, Pengyu Li, Pan Yan, Qunzhi Shi, Lin Liu Department of Pharmacy, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, People’s Republic of China*These ...
Lu H +6 more
doaj
Successful Treatment of Chronic Meningitis Caused by Scedosporium apiospermum With Oral Voriconazole [PDF]
Patrick Danaher, Elizabeth Walter
openalex +1 more source
In vitro activity of fluconazole and voriconazole against clinical isolates of Candida spp. by E-test method. [PDF]
The in vitro susceptibility of clinical Candida isolates towards fluconazole and voriconazole was determined using the E-test method. A total of 41 clinical isolates recovered from patients since 2004 until 2009 from two local hospitals in Kuala Lumpur ...
Chong, Pei Pei +3 more
core
Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections
Issam S. Hamadeh +11 more
openalex +1 more source
Failure of voriconazole to cure disseminated zygomycosis in an immunocompromised child [PDF]
Voriconazole is increasingly used as a first-line agent for empirical antifungal therapy of prolonged febrile neutropenia in paediatric cancer patients. We describe the case of a 9-year-old patient with stage IV Burkitt lymphoma, who developed pulmonary ...
Aebi, Christoph +6 more
core
Rhizopus oryzae intrinsic reduced voriconazole susceptibility is due to Cyp51Ap [PDF]
Daiana Macedo +3 more
openalex +1 more source
Voriconazole-induced Myositis in a Double Lung Transplant Recipient [PDF]
Mohanad Soliman +4 more
openalex +1 more source

